Michael T. Constantino serves as Executive at 9 METERS BIOPHARMA, INC., where they oversee executive responsibilities. Since joining the company, Michael T. Constantino has executed 10 insider transactions totaling $149.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 15, 2024 involved purchasing 3,100 shares valued at $19.5K.
Michael T. Constantino currently holds 12,350 shares of 9 METERS BIOPHARMA, INC. (NMTR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael T. Constantino has been a net buyer of NMTR stock. They have purchased $149.7K and sold $0 worth of shares.
Michael T. Constantino's most recent insider trade was on Aug 15, 2024, when they purchased 3,100 shares at $6.29 per share.
Get notified when new Form 4 filings are submitted
| $4.18 |
| Discretionary |
| Mar 29, 2023 | NMTR | $0 | Award | 7,885 | $N/A | Discretionary |
| May 23, 2022 | NMTR | $7.7K | Purchase | 16,000 | $0.48 | Discretionary |
| May 23, 2022 | HUMA | $9.7K | Purchase | 2,000 | $4.83 | Discretionary |
| Nov 22, 2021 | HUMA | $24.8K | Purchase | 2,300 | $10.79 | Discretionary |
| Nov 22, 2021 | HUMA | $2.2K | Purchase | 200 | $10.83 | Discretionary |
| Aug 24, 2021 | NMTR | $20.5K | Purchase | 18,000 | $1.14 | Discretionary |
| Aug 20, 2020 | NMTR | $19.9K | Purchase | 26,508.74 | $0.75 | Discretionary |
| Aug 20, 2020 | NMTR | $25.6K | Purchase | 34,108 | $0.75 | Discretionary |